Literature DB >> 30721158

An SFTPC BRICHOS mutant links epithelial ER stress and spontaneous lung fibrosis.

Jeremy Katzen1, Brandie D Wagner2, Alessandro Venosa1, Meghan Kopp1, Yaniv Tomer1, Scott J Russo1, Alvis C Headen1, Maria C Basil1, James M Stark3, Surafel Mulugeta1, Robin R Deterding4, Michael F Beers1,5.   

Abstract

Alveolar type 2 (AT2) cell endoplasmic reticulum (ER) stress is a prominent feature in adult and pediatric interstitial lung disease (ILD and ChILD), but in vivo models linking AT2 cell ER stress to ILD have been elusive. Based on a clinical ChILD case, we identified a critical cysteine residue in the surfactant protein C gene (SFTPC) BRICHOS domain whose mutation induced ER stress in vitro. To model this in vivo, we generated a knockin mouse model expressing a cysteine-to-glycine substitution at codon 121 (C121G) in the Sftpc gene. SftpcC121G expression during fetal development resulted in a toxic gain-of-function causing fatal postnatal respiratory failure from disrupted lung morphogenesis. Induced SftpcC121G expression in adult mice resulted in an ER-retained pro-protein causing AT2 cell ER stress. SftpcC121G AT2 cells were a source of cytokines expressed in concert with development of polycellular alveolitis. These cytokines were subsequently found in a high-dimensional proteomic screen of bronchoalveolar lavage fluid from ChILD patients with the same class of SFTPC mutations. Following alveolitis resolution, SftpcC121G mice developed spontaneous pulmonary fibrosis and restrictive lung impairment. This model provides proof of concept linking AT2 cell ER stress to fibrotic lung disease coupled with translationally relevant biomarkers.

Entities:  

Keywords:  Cell stress; Fibrosis; Protein misfolding; Pulmonology

Mesh:

Substances:

Year:  2019        PMID: 30721158      PMCID: PMC6483196          DOI: 10.1172/jci.insight.126125

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  84 in total

Review 1.  Childhood interstitial lung diseases: an 18-year retrospective analysis.

Authors:  Jennifer J Soares; Gail H Deutsch; Paul E Moore; Mohammad F Fazili; Eric D Austin; Rebekah F Brown; Andrew G Sokolow; Melissa A Hilmes; Lisa R Young
Journal:  Pediatrics       Date:  2013-09-30       Impact factor: 7.124

2.  Flow cytometric analysis of macrophages and dendritic cell subsets in the mouse lung.

Authors:  Alexander V Misharin; Luisa Morales-Nebreda; Gökhan M Mutlu; G R Scott Budinger; Harris Perlman
Journal:  Am J Respir Cell Mol Biol       Date:  2013-10       Impact factor: 6.914

3.  The unfolded protein response is an important regulator of inflammatory genes in endothelial cells.

Authors:  Peter S Gargalovic; Nima M Gharavi; Michael J Clark; Joanne Pagnon; Wen-Pin Yang; Aiqing He; Amy Truong; Tamar Baruch-Oren; Judith A Berliner; Todd G Kirchgessner; Aldons J Lusis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-08-24       Impact factor: 8.311

4.  A nonaggregating surfactant protein C mutant is misdirected to early endosomes and disrupts phospholipid recycling.

Authors:  Michael F Beers; Arie Hawkins; Jean Ann Maguire; Adam Kotorashvili; Ming Zhao; Jennifer L Newitt; Wenge Ding; Scott Russo; Susan Guttentag; Linda Gonzales; Surafel Mulugeta
Journal:  Traffic       Date:  2011-06-28       Impact factor: 6.215

5.  Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis.

Authors:  Michael A Gibbons; Alison C MacKinnon; Prakash Ramachandran; Kevin Dhaliwal; Rodger Duffin; Alexander T Phythian-Adams; Nico van Rooijen; Christopher Haslett; Sarah E Howie; A John Simpson; Nikhil Hirani; Jack Gauldie; John P Iredale; Tariq Sethi; Stuart J Forbes
Journal:  Am J Respir Crit Care Med       Date:  2011-09-01       Impact factor: 21.405

Review 6.  An official American Thoracic Society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy.

Authors:  Geoffrey Kurland; Robin R Deterding; James S Hagood; Lisa R Young; Alan S Brody; Robert G Castile; Sharon Dell; Leland L Fan; Aaron Hamvas; Bettina C Hilman; Claire Langston; Lawrence M Nogee; Gregory J Redding
Journal:  Am J Respir Crit Care Med       Date:  2013-08-01       Impact factor: 21.405

7.  Differential extraction for the rapid purification of bovine surfactant protein B.

Authors:  M F Beers; S R Bates; A B Fisher
Journal:  Am J Physiol       Date:  1992-06

8.  Targeted Type 2 Alveolar Cell Depletion. A Dynamic Functional Model for Lung Injury Repair.

Authors:  Orquidea Garcia; Michael J Hiatt; Amber Lundin; Jooeun Lee; Raghava Reddy; Sonia Navarro; Alex Kikuchi; Barbara Driscoll
Journal:  Am J Respir Cell Mol Biol       Date:  2016-03       Impact factor: 6.914

9.  Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases.

Authors:  M Suga; K Iyonaga; H Ichiyasu; N Saita; H Yamasaki; M Ando
Journal:  Eur Respir J       Date:  1999-08       Impact factor: 16.671

10.  Misfolded BRICHOS SP-C mutant proteins induce apoptosis via caspase-4- and cytochrome c-related mechanisms.

Authors:  Surafel Mulugeta; Jean Ann Maguire; Jennifer L Newitt; Scott J Russo; Adam Kotorashvili; Michael F Beers
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-06-22       Impact factor: 5.464

View more
  40 in total

Review 1.  Lung regeneration: a tale of mice and men.

Authors:  Maria C Basil; Edward E Morrisey
Journal:  Semin Cell Dev Biol       Date:  2019-11-21       Impact factor: 7.727

2.  Epithelial Expression of an Interstitial Lung Disease-Associated Mutation in Surfactant Protein-C Modulates Recruitment and Activation of Key Myeloid Cell Populations in Mice.

Authors:  Alessandro Venosa; Jeremy Katzen; Yaniv Tomer; Meghan Kopp; Sarita Jamil; Scott J Russo; Surafel Mulugeta; Michael F Beers
Journal:  J Immunol       Date:  2019-03-25       Impact factor: 5.422

Review 3.  You Say You Want a Resolution (of Fibrosis).

Authors:  Kamran Atabai; Christopher D Yang; Michael J Podolsky
Journal:  Am J Respir Cell Mol Biol       Date:  2020-10       Impact factor: 6.914

Review 4.  Contributions of alveolar epithelial cell quality control to pulmonary fibrosis.

Authors:  Jeremy Katzen; Michael F Beers
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

Review 5.  Familial Interstitial Lung Disease.

Authors:  Jonathan A Kropski
Journal:  Semin Respir Crit Care Med       Date:  2020-04-12       Impact factor: 3.119

Review 6.  Approaching Clinical Trials in Childhood Interstitial Lung Disease and Pediatric Pulmonary Fibrosis.

Authors:  Robin R Deterding; Emily M DeBoer; Michal J Cidon; Terry E Robinson; David Warburton; Gail H Deutsch; Lisa R Young
Journal:  Am J Respir Crit Care Med       Date:  2019-11-15       Impact factor: 21.405

7.  Functional characterization of four ATP-binding cassette transporter A3 gene (ABCA3) variants.

Authors:  June Y Hu; Ping Yang; Daniel J Wegner; Hillary B Heins; Cliff J Luke; Fuhai Li; Frances V White; Gary A Silverman; F Sessions Cole; Jennifer A Wambach
Journal:  Hum Mutat       Date:  2020-04-01       Impact factor: 4.878

8.  FGFR2 Is Required for AEC2 Homeostasis and Survival after Bleomycin-induced Lung Injury.

Authors:  Samuel J Dorry; Brandon O Ansbro; David M Ornitz; Gökhan M Mutlu; Robert D Guzy
Journal:  Am J Respir Cell Mol Biol       Date:  2020-05       Impact factor: 6.914

9.  Grp78 Loss in Epithelial Progenitors Reveals an Age-linked Role for Endoplasmic Reticulum Stress in Pulmonary Fibrosis.

Authors:  Zea Borok; Masafumi Horie; Per Flodby; Hongjun Wang; Yixin Liu; Sivagini Ganesh; Amy L Firth; Parviz Minoo; Changgong Li; Michael F Beers; Amy S Lee; Beiyun Zhou
Journal:  Am J Respir Crit Care Med       Date:  2020-01-15       Impact factor: 21.405

10.  Senescence of Alveolar Type 2 Cells Drives Progressive Pulmonary Fibrosis.

Authors:  Changfu Yao; Xiangrong Guan; Gianni Carraro; Tanyalak Parimon; Xue Liu; Guanling Huang; Apoorva Mulay; Harmik J Soukiasian; Gregory David; Stephen S Weigt; John A Belperio; Peter Chen; Dianhua Jiang; Paul W Noble; Barry R Stripp
Journal:  Am J Respir Crit Care Med       Date:  2021-03-15       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.